Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydroxamates as therapeutic agents

Hydroxamates as therapeutic agents

US Patent 8779171 · Granted Jul 15, 2014

Estimated economic value: $38,579,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for in2025
Quinolone derivatives as fibroblast growth factor receptor inhibitors2024
Signal variation measurement2024
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for in2024
Triazolopyrimidine compounds and uses thereof2024
Compounds and compositions for inhibiting the activity of SHP22024
Signal delay measurement2023
Use of inhibitors of Brutons tyrosine kinase (Btk)2023
Compounds and methods for modulating Bruton's Tyrosine Kinase2022
Compounds and methods for modulating adenosine A2B receptor and adenosine A2A re2022
Triazolopyrimidine compounds and uses thereof2021
Quinolone derivatives as fibroblast growth factor receptor inhibitors2021